Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009

Pharmacoepidemiology and Drug Safety

Volumn 22, Issue 8, 2013, Pages 842-849

  Asgari, Maryam M ^a,b   Wu, Jashin J ^c   Gelfand, Joel M ^d   Salman, Craig ^a   Curtis, Jeffrey R ^e   Harrold, Leslie R ^f   Herrinton, Lisa J ^a  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e University of Alabama at Birmingham   (United States)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Computerized medical information; Epidemiology; Incidence, prevalence, health maintenance organizations; Pharmacoepidemiology; Psoriasis; Psoriatic arthritis

Indexed keywords

ARTICLE; AUTOMATION; DERMATOLOGIST; HUMAN; ICD-9-CM; INTEGRATED HEALTH CARE SYSTEM; MANAGED CARE; MEDICAL INFORMATICS; MEDICAL RECORD REVIEW; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RHEUMATOLOGY; SENSITIVITY ANALYSIS; VALIDITY;

COMPUTERIZED MEDICAL INFORMATION; EPIDEMIOLOGY; INCIDENCE, PREVALENCE, HEALTH MAINTENANCE ORGANIZATIONS; PHARMACOEPIDEMIOLOGY; PSORIASIS; PSORIATIC ARTHRITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ARTHRITIS, PSORIATIC; CLINICAL CODING; DELIVERY OF HEALTH CARE, INTEGRATED; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PSORIASIS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84880756778     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3447     Document Type: Article

References (35)

1. Schön MP, Boehncke WH. Psoriasis. N Engl J Med 2005; 352(18): 1899-912.
2. Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 1996; 14(3): 485-96.
3. Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005; 53(4): 573.
4. Lima XT, Minnillo R, Spencer JM, Kimball AB. Psoriasis prevalence among the 2009 AAD National Melanoma/Skin Cancer Screening Program participants. J Eur Acad Dermatol Venereol. 2012 Apr 4. doi: 10.1111/j.1468-3083.2012.04531. PubMed PMID: 22471885.
5. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades: a population-based study. J Rheumatol 2009; 36(2): 361-7.
6. Gelfand JM, Stern RS, Nijsten T, et al. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol 2005; 52(1): 23-6.
7. Wu JJ, Black MH, Smith N, Porter AH, Jacobsen SJ, Koebnick C. Low prevalence of psoriasis among children and adolescents in a large multiethnic cohort in southern California. J Am Acad Dermatol 2011; 65(5): 957-64.
8. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9(2): 136-9.
9. Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 2009; 60(2): 218-24.
10. Gordon NP. Similarity of the Adult Kaiser Permanente Membership in Northern California to the Insured and General Population in Northern California: Statistics from the 2009 California Health Interview Survey. Internal Division of Research report. Oakland, CA: Kaiser Permanente Division of Research; Jan 2012. Available at: http://www.dor.kaiser.org/external/chis_non_kp_2009. Accessed September 16, 2012.
11. Taylor WJ, Helliwell PS. Development of diagnostic criteria for psoriatic arthritis: methods and process. Curr Rheumatol Rep. 2004 Aug; 6(4): 299-305. Review. PubMed PMID: 15251082.
12. Garwood F. Fiducial Limits for the Poisson Distribution. Biometrica 1936; 28: 437-442.
13. U.S. Census Bureau; " National Level Census Data for the United States: 2000;" published April 2, 2001, http://www.census.gov/population/cen2000/phc-t1/tab01.txt
14. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: Principles and quantitative methods. Van Nostrand Reinhold: New York, 1982, p 98.
15. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence. J Invest Dermatol. 2012 Sep 27. doi: 10.1038/jid.2012.339.
16. Robinson D, Jr, Hackett M, Wong J, Kimball AB, Cohen R, Bala M. IMID Study Group. Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001-2002. Curr Med Res Opin 2006 May; 22(5): 989-1000.
17. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005; 141(12): 1537-41.
18. Seminara NM, Abuabara K, Shin DB, et al. Validity of The Health Improvement Network (THIN) for the study of psoriasis. Br J Dermatol 2011; 164(3): 602-9.
19. Huerta C, Rivero E, Rodríguez LA. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007 Dec; 143(12): 1559-65.
20. Icen M, Crowson CS, McEvoy MT, Gabriel SE, Maradit KH. Potential misclassification of patients with psoriasis in electronic databases. J Am Acad Dermatol 2008 Dec; 59(6): 981-5.
21. Tsai TF, Wang TS, Hung ST, et al. Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J Dermatol Sci 2011; 63(1): 40-6.
22. Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 2010; 34(3): J314-21.
23. Augustin M, Herberger K, Hintzen S, Heigel H, Franzke N, Schäfer I. Prevalence of skin lesions and need for treatment in a cohort of 90 880 workers. Br J Dermatol 2011; 165(4): 865-73.
24. Schaefer I, Rustenbach SJ, Zimmer L, Augustin M. Prevalence of skin diseases in a cohort of 48, 665 employees in Germany. Dermatology 2008; 217(2): 169-72.
25. Sardu C, Cocco E, Mereu A, et al. Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. PLoS One. 2012; 7(3): e32487.
26. Li YH, Wang SY, Pan SS, Li C, Wang HY, Li ZG. Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology (Oxford) 2012; 51(4): 721-9.
27. Pedersen OB, Svendsen AJ, Ejstrup L, Skytthe A, Junker P. The occurrence of psoriatic arthritis in Denmark. Ann Rheum Dis 2008; 67(10): 1422-6.
28. Hanova P, Pavelka K, Holcatova I, Pikhart H. Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic. Scand J Rheumatol 2010; 39(4): 310-7.
29. Soriano ER, Rosa J, Velozo E, et al. Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study. Rheumatology (Oxford) 2011; 50(4): 729-34.
30. Nossent JC, Gran JT. Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway. Scand J Rheumatol 2009; 38(4): 251-5. PubMed PMID: 19247847.
31. Yang Q, Qu L, Tian H, et al. Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis. J Eur Acad Dermatol Venereol 2011; 25(12): 1409-14.
32. Catanoso M, Pipitone N, Salvarani C. Epidemiology of psoriatic arthritis. Reumatismo 2012 Jun 5; 64(2): 66-70.
33. Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum. 2009;61(10):1373-8. 30. Radtke MA, Reich K, Blome C, Rustenbach S, Augustin M. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol 2009; 23(6): 683-91.
34. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005 Mar; 64(Suppl 2): ii14-7.
35. Minnesota demographics. http://www.minnesota-demographics.com/olmsted-county-demographics, Accessed September 26, 2012.